Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Long-term and sequential treatment for osteoporosis
I Foessl, HP Dimai, B Obermayer-Pietsch - Nature Reviews …, 2023 - nature.com
Osteoporosis is a skeletal disorder that causes impairment of bone structure and strength,
leading to a progressively increased risk of fragility fractures. The global prevalence of …
leading to a progressively increased risk of fragility fractures. The global prevalence of …
The dental management of patients at risk of medication‐related osteonecrosis of the jaw: new paradigm of primary prevention
Medication‐related osteonecrosis of the jaw (MRONJ) is a serious adverse reaction of
antiresorptive and antiangiogenic agents; it is a potentially painful and debilitating condition …
antiresorptive and antiangiogenic agents; it is a potentially painful and debilitating condition …
[HTML][HTML] Medication-related osteonecrosis of jaws (MRONJ) prevention and diagnosis: Italian consensus update 2020
The Medication-Related Osteonecrosis of Jaws (MRONJ) diagnosis process and its
prevention play a role of great and rising importance, not only on the Quality of Life (QoL) of …
prevention play a role of great and rising importance, not only on the Quality of Life (QoL) of …
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
Guidance is provided in a European setting on the assessment and treatment of
postmenopausal women at risk from fractures due to osteoporosis. Introduction The …
postmenopausal women at risk from fractures due to osteoporosis. Introduction The …
Executive summary of the European guidance for the diagnosis and management of osteoporosis in postmenopausal women
A guidance on the assessment and treatment of postmenopausal women at risk from
fractures due to osteoporosis was recently published in Osteoporosis International as a joint …
fractures due to osteoporosis was recently published in Osteoporosis International as a joint …
Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review
Introduction The reporting of osteonecrosis of the jaw (ONJ) related to anticancer agents
without known antiresorptive properties (non-antiresorptives), such as antiangiogenics …
without known antiresorptive properties (non-antiresorptives), such as antiangiogenics …
Prevalence, initiating factor, and treatment outcome of medication-related osteonecrosis of the jaw—a 4-year prospective study
F Hallmer, G Andersson, B Götrick, G Warfvinge… - Oral surgery, oral …, 2018 - Elsevier
Objectives Medication-related osteonecrosis of the jaw (MRONJ) has a wide range of
prevalence, and a standard therapy has not yet been established. The aim of this study was …
prevalence, and a standard therapy has not yet been established. The aim of this study was …
Workshop of european task force on medication related osteonecrosis of the jaw. Current challenges
This paper reports on the conclusions of two workshops held in Copenhagen in September
2017 and November 2018 focused on medication-related osteonecrosis of the jaws …
2017 and November 2018 focused on medication-related osteonecrosis of the jaws …
Italian position paper (SIPMO‐SICMF) on medication‐related osteonecrosis of the jaw (MRONJ)
Objective This paper aims to describe the 2023 update position paper on MRONJ
developed by the Italian Societies of Oral Pathology and Medicine (SIPMO) and of …
developed by the Italian Societies of Oral Pathology and Medicine (SIPMO) and of …
The preventive care of medication-related osteonecrosis of the jaw (MRONJ): a position paper by Italian experts for dental hygienists
R Mauceri, R Coniglio, A Abbinante, P Carcieri… - Supportive Care in …, 2022 - Springer
Purpose The prevention and early diagnosis of medication-related osteonecrosis of the jaw
(MRONJ) is fundamental to reducing the incidence and progression of MRONJ. Many in the …
(MRONJ) is fundamental to reducing the incidence and progression of MRONJ. Many in the …